Q2 2021 Trinity Biotech PLC Earnings Call Transcript
Good morning, everyone, and welcome to the Trinity Biotech Q2 2021 Financial Results Conference Call.
(Operator Instructions)
Please also note today's event is being recorded. At this time, I'd like to turn the conference call over to Joe Diaz with Lytham Partners. Sir, please go ahead.
Thank you, Jamie, and thanks to all of you for joining us today to review the financial results of Trinity Biotech for the second quarter of 2021, which ended on June 30, 2021. Joining us on today's call is Ronan O'Caoimh, Chairman and Chief Executive Officer of Trinity Biotech; and John Gillard, Chief Financial Officer. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
Before we begin, I must inform you that statements made in this conference call may be deemed forward-looking statements within the meaning of the federal securities laws. These statements are subject to known and unknown risks and uncertainties that may cause actual results to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |